STUDY OBJECTIVE: To describe our experience with three uterine @entity242 associated with hysteroscopic endometrial ablation. DESIGN: Cohort study (Canadian Task Force classification II-2). SETTING: University-affiliated teaching hospitals. @entity1 : Three of 2402 @entity1 undergoing hysteroscopic endometrial ablation who had uterine @entity242 . INTERVENTION: Hysteroscopic endomyometrial resection. MEASUREMENTS AND MAIN RESULTS: One low-grade @entity6019 and two @entity6962 were resected. After hysterectomy in two @entity1 , no @entity5 was identified in one of them. The third @entity1 was an 82-year-old @entity1 with moderate @entity931 who refused hysterectomy. After endomyometrial resection she remained amenorrheic for the last 14 months of her life. CONCLUSION: From our experience the incidence of uterine @entity242 is approximately 1/800 @entity1 undergoing hysteroscopic ablation for abnormal uterine @entity548 . Complete endomyometrial resection is feasible and may be offered as diagnostic and palliative therapy in @entity1 at high risk for hysterectomy.

Hysteroscopic endomyometrial resection of three uterine XXXX .

@entity1 :: ('9606', 'Species') :: ['women', 'patients', 'woman', 'patient', 'PATIENTS'] @entity242 :: ('MESH:D012509', 'Disease') :: ['sarcomas'] @entity548 :: ('MESH:D006470', 'Disease') :: ['bleeding'] @entity5 :: ('MESH:D009369', 'Disease') :: ['residual cancer'] @entity6019 :: ('MESH:D018203', 'Disease') :: ['endometrial stromal sarcoma'] @entity931 :: ('MESH:D008595', 'Disease') :: ['menorrhagia'] @entity6962 :: ('MESH:D002296', 'Disease') :: ['carcinosarcomas']
@entity242 :: (MESH:D012509,Disease) :: ['sarcomas']
